Not applicableUnknownNCT03964844What this trial is testingClostridium Difficile Infection (CDI) in Hematologic Patients.Who this might be right forC.Difficile Diarrhea Hospital General Universitario Gregorio Marañon 450
Large-scale testing (Phase 3)Study completedNCT02254811What this trial is testingFMT Delivered by Capsule Versus Colonoscopy for Recurrent C. DiffWho this might be right forEnterocolitis Clostridium Difficile Recurrent University of Alberta 116
Large-scale testing (Phase 3)UnknownNCT06107569What this trial is testingTreatment of CDI and Recurrence With Fecal Microbiota Transplant Using PromicrobiomaWho this might be right forClostridium Difficile Infections Hospital Universitario Evangelico de Curitiba 24
Early research (Phase 1)Study completedNCT02830542What this trial is testingSER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent RecurrenceWho this might be right forClostridium Difficile Infection Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02299570What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionWho this might be right forEnterocolitis Clostridium Difficile Recurrent Rebiotix Inc. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461What this trial is testingA Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.Who this might be right forIrritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more PharmaPlanter Technologies Inc 63
Post-approval studies (Phase 4)Study completedNCT03880539What this trial is testingBezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence University of Kansas Medical Center 4
Early research (Phase 1)Study completedNCT02865616What this trial is testingMET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)Who this might be right forClostridium Difficile Infection NuBiyota 19
Large-scale testing (Phase 3)Study completedNCT01241552What this trial is testingMK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)Who this might be right forClostridium Difficile Infection Merck Sharp & Dohme LLC 1,452
Testing effectiveness (Phase 2)Study completedNCT03353506What this trial is testingLyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff InfectionWho this might be right forEnterocolitisRecurrent Clostridium Difficile Infection Dina Kao 11
Testing effectiveness (Phase 2)Ended earlyNCT06536465What this trial is testingThe Clostridioides Difficile Trial of REC-3964Who this might be right forRecurrent Clostridioides Difficile Infection Recursion Pharmaceuticals Inc. 3
Large-scale testing (Phase 3)Study completedNCT05831189What this trial is testingA Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence Ferring Pharmaceuticals 41
Not applicableNot Yet RecruitingNCT06533800What this trial is testingEvaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile InfectionWho this might be right forCDI Fondazione Policlinico Universitario Agostino Gemelli IRCCS 24
Testing effectiveness (Phase 2)Study completedNCT03829475What this trial is testingICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDIWho this might be right forInflammatory Bowel DiseasesClostridium Difficile Infection Brigham and Women's Hospital 61
Not applicableStudy completedNCT05835219What this trial is testingREBYOTA™ Prospective RegistryWho this might be right forRecurrence of Clostridium Difficile Infection Ferring Pharmaceuticals 145
Testing effectiveness (Phase 2)Ended earlyNCT02255305What this trial is testingFMT Versus Antimicrobials for Initial Treatment of Recurrent CDIWho this might be right forClostridium Difficile Infection Endeavor Health 6
Testing effectiveness (Phase 2)Study completedNCT03110133What this trial is testingEfficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffWho this might be right forClostridium Difficile Infection Recurrence Finch Research and Development LLC. 206
Testing effectiveness (Phase 2)Ended earlyNCT03298048What this trial is testingDose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)Who this might be right forRecurrent C. Difficile Infection The University of Texas Health Science Center, Houston 17
Large-scale testing (Phase 3)Study completedNCT01513239What this trial is testingMK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)Who this might be right forClostridium Difficile Infection Merck Sharp & Dohme LLC 1,203
Not applicableNot Yet RecruitingNCT07120490What this trial is testingSTOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile InfectionWho this might be right forClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceFecal Microbiota Transplantation (FMT)+3 more Medical University of Warsaw 424